Catalyst Wire Dossier Catalyst Wire Dossier

SARS-CoV-2 Spike Ferritin Nanoparticle (SpFN) Vaccine with ALFQ Adjuvant

SpFN vaccine with ALFQ adjuvant · U.S. Army Medical Research and Development Command
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SARS-CoV-2 Spike Ferritin Nanoparticle (SpFN) Vaccine with ALFQ Adjuvant, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 [Phase 1]

See pricing